ICAR: Interest of early treatment with polyvalent immunoglobulins in the treatment of respiratory distress syndrome associated with SARS CoV-2 - ICAR (ivIg in ARVs linked to Covid)
- Funded by Ministre des Solidarités et de la Santé (France)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Ministre des Solidarités et de la Santé (France)Principal Investigator
Aurélien MazeraudResearch Location
FranceLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Supportive care, processes of care and management
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified